JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6526
KALA BIO
KALA
$7.02M
| $274 | ﹤0.01% |
1
| – | – |
2017 Q3
26 quarters
|
|
6527
Culp Inc
CULP
$48.8M
| $269 | ﹤0.01% |
56
-1,573
| -97% | -$7.89K |
2017 Q4
25 quarters
|
|
6528
Lee Enterprises
LEE
$155M
| $266 | ﹤0.01% |
20
| – | – |
2013 Q2
43 quarters
|
|
6529
ProShares Global Listed Private Equity ETF
PEX
$10.3M
| $266 | ﹤0.01% |
9
| – | – |
2022 Q4
5 quarters
|
|
|
ELBM
6530
Electra Battery Materials
ELBM
$54.4M
| $265 | ﹤0.01% |
14
+2
| +17% | +$4 |
2022 Q2
7 quarters
|
|
6531
Alpha Architect US Quantitative Momentum ETF
QMOM
$432M
| $265 | ﹤0.01% |
4
-3
| -43% | -$163 |
2023 Q4
1 quarter
|
|
|
EMKR
6532
DELISTED
Emcore Corp
EMKR
| $257 | ﹤0.01% |
74
+4
| +6% | +$19 |
2017 Q3
26 quarters
|
|
|
BFI
6533
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $254 | ﹤0.01% |
440
+12
| +3% | +$8 |
2020 Q4
13 quarters
|
|
6534
Recon Technology
RCON
$26.1M
| – | – |
0
| – | – |
2023 Q3
2 quarters
|
|
|
EZRAW
6535
DELISTED
Reliance Global Series A Warrants
EZRAW
| – | – |
0
| – | – |
2023 Q2
3 quarters
|
|
|
AUMN
6536
DELISTED
Golden Minerals Company
AUMN
| $252 | ﹤0.01% |
600
| – | – |
2013 Q2
43 quarters
|
|
6537
MoonLake Immunotherapeutics
MLTX
$965M
| $251 | ﹤0.01% |
5
-1,443
| -100% | -$78.3K |
2022 Q4
5 quarters
|
|
6538
Alpha Pro Tech
APT
$57.4M
| $250 | ﹤0.01% |
40
-19
| -32% | -$104 |
2020 Q2
15 quarters
|
|
6539
Intellicheck
IDN
$46M
| $240 | ﹤0.01% |
69
+13
| +23% | +$25 |
2020 Q2
15 quarters
|
|
|
TBIO
6540
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $234 | ﹤0.01% |
30
+2
| +7% | +$15 |
2021 Q3
10 quarters
|
|
6541
NRX Pharmaceuticals
NRXP
$123M
| $232 | ﹤0.01% |
49
-1,632
| -97% | -$7.52K |
2021 Q3
10 quarters
|
|
|
DGXX
6542
Digi Power X Inc
DGXX
$376M
| $231 | ﹤0.01% |
158
-1,897
| -92% | -$3.18K |
2023 Q3
2 quarters
|
|
|
LITS
6543
Lite Strategy Inc
LITS
$43.2M
| $228 | ﹤0.01% |
57
+4
| +8% | +$18 |
2018 Q2
23 quarters
|
|
6544
American Resources Corp
AREC
$191M
| $227 | ﹤0.01% |
161
-19,141
| -99% | -$28.3K |
2023 Q3
2 quarters
|
|
6545
Espey Mfg & Electronics Corp
ESP
$178M
| $227 | ﹤0.01% |
9
+2
| +29% | +$46 |
2022 Q3
6 quarters
|
|
6546
Milestone Scientific
MLSS
$36.2M
| $223 | ﹤0.01% |
358
+29
| +9% | +$19 |
2020 Q2
15 quarters
|
|
6547
Innovator US Equity Ultra Buffer ETF July
UJUL
$303M
| $223 | ﹤0.01% |
7
| – | – |
2023 Q3
2 quarters
|
|
|
CLLS
6548
Cellectis
CLLS
$139M
| $220 | ﹤0.01% |
83
| – | – |
2020 Q1
16 quarters
|
|
|
ARBK
6549
Argo Blockchain
ARBK
$32.2M
| – | – |
-21
| Closed | -$9.92K | – |
|
6550
First Guaranty Bancshares
FGBI
$137M
| $213 | ﹤0.01% |
21
| – | – |
2017 Q4
25 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.